130 related articles for article (PubMed ID: 3598911)
1. Hemodynamic and regional blood flow response to piroximone (MDL 19,205) in dogs with congestive heart failure: a comparison with dobutamine.
Petein M; Heppner B; Bache RJ; Cohn JN; Pierpont GL
J Pharmacol Exp Ther; 1987 Jun; 241(3):956-60. PubMed ID: 3598911
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure.
Petein M; Levine TB; Cohn JN
J Am Coll Cardiol; 1984 Aug; 4(2):364-71. PubMed ID: 6736478
[TBL] [Abstract][Full Text] [Related]
3. Systemic and regional hemodynamic effects of isomazole in awake dogs with congestive heart failure.
Imai N; Liang CS; Stone CK; Hayes JS; Hood WB
J Pharmacol Exp Ther; 1987 Apr; 241(1):20-6. PubMed ID: 3572783
[TBL] [Abstract][Full Text] [Related]
4. Persistent hemodynamic effects without long-term clinical benefits in response to oral piroximone (MDL 19,205) in patients with congestive heart failure.
Petein M; Levine TB; Cohn JN
Circulation; 1986 Mar; 73(3 Pt 2):III230-6. PubMed ID: 3510778
[TBL] [Abstract][Full Text] [Related]
5. Combined hemodynamic and scintigraphic assessment of piroximone (MDL 19,205) and comparison with dobutamine and nitroprusside.
Massie BM; Cornyn J; Topic N; Loge D; Podolin RA
Am J Cardiol; 1987 Sep; 60(8):647-53. PubMed ID: 3661429
[TBL] [Abstract][Full Text] [Related]
6. Effects of dobutamine on left ventricular performance, coronary dynamics, and distribution of cardiac output in conscious dogs.
Vatner SF; McRitchie RJ; Braunwald E
J Clin Invest; 1974 May; 53(5):1265-73. PubMed ID: 4825224
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular effects of the new cardiotonic agent 1,2-dihydro-6-methyl-2-oxo-5-(imidazo[1,2-a]pyridin-6-yl)-3-pyridine carbonitrile hydrochloride monohydrate. 2nd communication: studies in dogs.
Ohhara H; Ogawa T; Takeda M; Katoh H; Daiku Y; Igarashi T
Arzneimittelforschung; 1989 Jan; 39(1):38-45. PubMed ID: 2719742
[TBL] [Abstract][Full Text] [Related]
8. Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
Uretsky BF; Valdes AM; Reddy PS
Circulation; 1986 Mar; 73(3 Pt 2):III219-29. PubMed ID: 2935328
[TBL] [Abstract][Full Text] [Related]
9. [Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
Drexler H; Faude F; Winterer H; Wollschläger H; Freudenberg N; Just H
Z Kardiol; 1987 Aug; 76(8):507-13. PubMed ID: 3314215
[TBL] [Abstract][Full Text] [Related]
10. Effects of milrinone on systemic hemodynamics and regional circulations in dogs with congestive heart failure: comparison with dobutamine.
Liang CS; Thomas A; Imai N; Stone CK; Kawashima S; Hood WB
J Cardiovasc Pharmacol; 1987 Nov; 10(5):509-16. PubMed ID: 2447398
[TBL] [Abstract][Full Text] [Related]
11. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
12. Regional effects of dobutamine in endotoxic shock.
De Backer D; Zhang H; Manikis P; Vincent JL
J Surg Res; 1996 Oct; 65(2):93-100. PubMed ID: 8903453
[TBL] [Abstract][Full Text] [Related]
13. Comparison of catecholamine effects on canine myocardial metabolism and regional blood flow during and after cardiopulmonary bypass.
Ward HB; Einzig S; Wang T; Bianco RW; Foker JE
J Thorac Cardiovasc Surg; 1984 Mar; 87(3):452-65. PubMed ID: 6700252
[TBL] [Abstract][Full Text] [Related]
14. Regional alterations of left ventricular contraction and inotropic reserve in conscious dogs with heart failure.
Su JB; Barbe F; Laplace M; Crozatier B; Hittinger L
Cardiovasc Res; 1995 Dec; 30(6):848-56. PubMed ID: 8746198
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic and clinical evaluation of piroximone, a new inotrope-vasodilator agent, in severe congestive heart failure.
Axelrod RJ; De Marco T; Dae M; Botvinick EH; Chatterjee K
J Am Coll Cardiol; 1987 May; 9(5):1124-30. PubMed ID: 3571752
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
Saitoh C; Momose K; Tanaka H; Sato S; Taguchi K; Saitoh M; Maehara J; Asano M; Usuda S
Arzneimittelforschung; 1998 Feb; 48(2):125-32. PubMed ID: 9541721
[TBL] [Abstract][Full Text] [Related]
17. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
Olivari MT; Levine TB; Cohn JN
J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
[TBL] [Abstract][Full Text] [Related]
18. Acute hemodynamic effects of piroximone (MDL 19,205) in patients with moderate congestive heart failure: comparison with sodium nitroprusside.
Arbogast R; Brandt CM; Fincker JL; Schechter PJ
J Cardiovasc Pharmacol; 1986; 8(1):82-9. PubMed ID: 2419699
[TBL] [Abstract][Full Text] [Related]
19. A comparison of digoxin and dobutamine in patients with acute infarction and cardiac failure.
Goldstein RA; Passamani ER; Roberts R
N Engl J Med; 1980 Oct; 303(15):846-50. PubMed ID: 7412802
[TBL] [Abstract][Full Text] [Related]
20. Piroximone, dobutamine and nitroprusside: comparative effects on haemodynamics in patients with congestive heart failure.
Baumann G; Ningel K; Vieweg J; Joder-Ohlenbusch AM; Cremer G
Eur Heart J; 1991 Apr; 12(4):533-40. PubMed ID: 2065688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
